Suzanne Scott is a Health Psychologist and Senior Lecturer in Health Psychology at King’s College London.
Using an array of methodological approaches, and studying a range of cancer types, her work has advanced the understanding of symptom perception, symptom appraisal and help-seeking behaviour for symptoms suggestive of cancer. With CanTest Senior Faculty members Dr Fiona Walter and Prof Jon Emery, she developed the Model of Pathways to Treatment: a framework for understanding the processes and events that may occur prior to diagnosis and treatment of cancer (and other diseases).
Suzanne’s work has been used to develop and evaluate theory-based interventions to encourage timely healthcare use, including training for the dental team in how to communicate about oral cancer during routine consultations.
Suzanne’s other research interests include developing valid and reliable measurement tools for use in early diagnosis research and use of behavioural science to understand acceptability of diagnostics tests within primary care.
Follow Suzanne on Twitter @Suzanne_Scott
+44 (0)20 7848 8479
King’s College London, UK
Psychology; Behavioural Science, Early Diagnosis
- Moodley J, Scott SE, Mwaka AD, Constant D, Githaiga JN, Stewart TS, Payne A, Cairncross L, Somdyala NIM, Walter FM. Development and validation of the African Women Awareness of CANcer (AWACAN) tool for breast and cervical cancer. PLoS ONE, 2019, 14(8):e0220545, doi: 10.1371/journal.pone.0220545
- Walter FM, Penfold C, Joannides A, Saji S, Johnson M, Watts C, Brodbelt A, Jenkinson MD, Price SJ, Hamilton W, Scott SE. Missed opportunities for diagnosing brain tumours in primary care: a qualitative study of patient experiences. Br J Gen Pract, 2019, bjgp19X701861. DOI: 10.3399/bjgp19X70186
- Scott SE, Penfold C, Saji S, Curtis S, Watts C, Hamilton W, Joannides AJ, Walter FM. ‘It was nothing that you would think was anything’: Qualitative analysis of appraisal and help seeking preceding brain cancer diagnosis. PLoS ONE, 2019, 14:3, e02135
- Jones D, Neal RD, Duffy SRG, Scott SE, Whitaker KL, Brain K. Impact of the COVID-19 pandemic on the symptomatic diagnosis of cancer: the view from primary care. The Lancet Oncology, 2020. doi: 10.1016/S1470-2045(20)30242-4
- Sud A, Jones ME, Broggio J, Loveday C, Torr B, Garrett A, Nicol DL, Jhanji S, Boyce SA, Gronthoud F, Ward P, Handy JM, Yousaf N, Larkin J, Suh Y-E, Scott S, Pharoah PDP, Swanton C, Abbosh C, Williams M, Lyratzopoulos G, Houlston R, Turnbull C. Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic. Annals of Oncology, 2020, 31(8): 1065-1074, doi: 10.1016/j.annonc.2020.05.009
- Sud A, Jones M, Broggio J, Scott S, Loveday C, Torr B, Garrett A, Nicol DL, Jhanji S, Boyce SA, Williams M, Lyratzopoulos G, Barry C, Riboli E, Kipps E, McFerran E, Lawler M, Muller DC, Abulafi M, Houlston R, Turnbull CA. Quantifying and mitigating the impact of the COVID-19 pandemic on outcomes in colorectal cancer. Gut, 2020, doi: 10.1101/2020.04.28.20083170
- Sud A, Torr B, Jones ME, Broggio J, Scott S, Loveday C, Garrett A, Gronthoud F, Nicol DL, Jhanji S, Boyce SA, Williams M, Riboli E, Muller DC, Kipps E, Larkin J, Navani N, Swanton C, Lyratzopoulos G, McFerran E, Lawler M, Houlston R, Turnbull C. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study. The Lancet Oncology, 2020, 21(8): 1035-1044, doi: 10.1016/S1470-2045(20)30392-2